POLYMEROPOULOS MIHAEL HRISTOS 1355537 Data last updated 2024-05-14 07:02:16 -0500 US CDT

Latest Holdings

Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.


Non-derivative Transactions     CSV download

Tips: type "code_s" to show transactions with code "S".

Filing Date Transaction Date Operation Date Original Filing Reporter Relation Opr Amounta %(Owned)b ‱(SO)c Avg Prcd Account Type Full Name Code Remain Shares Outstanding (Million)e
2024-02-21 2024-02-16 2024-02-16 4 Polymeropoulos Mihael Hristos PRESIDENT AND CEO, CHAIRMAN OF THE BOARD acq 450000.0 23.35 78.21 0.0 Direct Common Stock VANDA PHARMACEUTICALS INC.

code_A

code  A
1926902.0 57.54 (VNDA)
2024-03-06 2024-03-04 2024-03-04 to 2024-03-05 4 Polymeropoulos Mihael Hristos PRESIDENT AND CEO, CHAIRMAN OF THE BOARD dsp 55172.0 2.86 9.59 4.19 Direct Common Stock VANDA PHARMACEUTICALS INC.

code_S

code  S
1871730.0 thumbnail 57.54 (VNDA)

Derivative Transactions

Tips: type "code_m" to show transactions with code "M".

Filing Date Transaction Date Operation Date Original Filing Reporter Relation Opr Amounta %(Owned)b ‱(SO)c Avg Prcd Account Type Full Name Code Remain Shares Outstanding (Million)e

a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)